Literature DB >> 11744173

The development and testing of a new temperature-sensitive drug delivery system for the treatment of solid tumors.

D Needham1, M W Dewhirst.   

Abstract

Our laboratories have been working together in close collaboration for over 10 years concerning the design and performance of lipid-based drug delivery systems. Over the past 3 years we have conceived of, developed, and tested pre-clinically, a new liposome-based temperature-sensitive drug delivery system for the treatment of solid tumors. This work is reported in a series of four publications: "J. Liposome Res. 9 (1999) 491; Cancer Res. Adv. Brief 60(5) (2000) 1197; Cancer Res. 6(9) (2000) 748; and Cancer Res. 60 (2000) 6950". Following a brief introduction concerning the motivations behind the work, this article will review these studies, including some of our earlier work that led to these ideas, and will present the rational design of the new liposome formulation from a materials engineering perspective.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11744173     DOI: 10.1016/s0169-409x(01)00233-2

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  96 in total

1.  Nanotechnology for energy-based cancer therapies.

Authors:  Kyle Gilstrap; Xiaoxiao Hu; Xiongbin Lu; Xiaoming He
Journal:  Am J Cancer Res       Date:  2011-03-11       Impact factor: 6.166

2.  Targeted drug delivery by high intensity focused ultrasound mediated hyperthermia combined with temperature-sensitive liposomes: computational modelling and preliminary in vivovalidation.

Authors:  Astrid Gasselhuber; Matthew R Dreher; Ari Partanen; Pavel S Yarmolenko; David Woods; Bradford J Wood; Dieter Haemmerich
Journal:  Int J Hyperthermia       Date:  2012       Impact factor: 3.914

3.  Mathematical spatio-temporal model of drug delivery from low temperature sensitive liposomes during radiofrequency tumour ablation.

Authors:  Astrid Gasselhuber; Matthew R Dreher; Ayele Negussie; Bradford J Wood; Frank Rattay; Dieter Haemmerich
Journal:  Int J Hyperthermia       Date:  2010       Impact factor: 3.914

Review 4.  Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers.

Authors:  Mary Caldorera-Moore; Nathalie Guimard; Li Shi; Krishnendu Roy
Journal:  Expert Opin Drug Deliv       Date:  2010-04       Impact factor: 6.648

5.  Inside-outside self-assembly of light-activated fast-release liposomes.

Authors:  Natalie Forbes; Jeong Eun Shin; Maria Ogunyankin; Joseph A Zasadzinski
Journal:  Phys Chem Chem Phys       Date:  2015-03-02       Impact factor: 3.676

Review 6.  Rationale for and measurement of liposomal drug delivery with hyperthermia using non-invasive imaging techniques.

Authors:  Jessica A Tashjian; Mark W Dewhirst; David Needham; Benjamin L Viglianti
Journal:  Int J Hyperthermia       Date:  2008-02       Impact factor: 3.914

7.  Comparison of thermally actuated retro-diels-alder release groups for nanoparticle based nucleic acid delivery.

Authors:  Mohammad Abu-Laban; Raju R Kumal; Jonathan Casey; Jeff Becca; Daniel LaMaster; Carlos N Pacheco; Dan G Sykes; Lasse Jensen; Louis H Haber; Daniel J Hayes
Journal:  J Colloid Interface Sci       Date:  2018-04-24       Impact factor: 8.128

8.  Temperature-sensitive liposome-mediated delivery of thrombolytic agents.

Authors:  Vishal Saxena; Carmen Gacchina Johnson; Ayele H Negussie; Karun V Sharma; Matthew R Dreher; Bradford J Wood
Journal:  Int J Hyperthermia       Date:  2015-03-13       Impact factor: 3.914

9.  Formation of stable nanocarriers by in situ ion pairing during block-copolymer-directed rapid precipitation.

Authors:  Nathalie M Pinkerton; Arnaud Grandeury; Andreas Fisch; Jörg Brozio; Bernd U Riebesehl; Robert K Prud'homme
Journal:  Mol Pharm       Date:  2012-12-24       Impact factor: 4.939

Review 10.  Thermosensitive liposomes for localized delivery and triggered release of chemotherapy.

Authors:  Terence Ta; Tyrone M Porter
Journal:  J Control Release       Date:  2013-04-11       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.